Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Long-term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort.

Jamil ML, Keeley J, Sood A, Dalela D, Arora S, Peabody JO, Trinh QD, Menon M, Rogers CG, Abdollah F.

Eur Urol. 2019 Nov 6. pii: S0302-2838(19)30835-8. doi: 10.1016/j.eururo.2019.10.028. [Epub ahead of print]

PMID:
31703971
2.

Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.

Lu Z, Williamson SR, Carskadon S, Arachchige PD, Dhamdhere G, Schultz DS, Stricker H, Peabody JO, Jeong W, Chitale DA, Bismar TA, Rogers CG, Menon M, Gupta NS, Palanisamy N.

Prostate. 2020 Jan;80(1):38-50. doi: 10.1002/pros.23914. Epub 2019 Oct 4.

PMID:
31584209
3.

Urologic Pathology: Key Parameters from a Urologist's Perspective.

Borchert A, Rogers CG.

Surg Pathol Clin. 2018 Dec;11(4):893-901. doi: 10.1016/j.path.2018.07.012. Epub 2018 Oct 17. Review.

PMID:
30447847
4.

Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases.

Arora S, Sood A, Dalela D, Tang HJ, Patel A, Keeley J, Trinh QD, Rogers CG, Menon M, Abdollah F.

Eur Urol. 2019 Feb;75(2):352-353. doi: 10.1016/j.eururo.2018.10.054. Epub 2018 Nov 9. No abstract available.

PMID:
30420256
5.

Retroperitoneal vs Transperitoneal Robot-assisted Partial Nephrectomy: Comparison in a Multi-institutional Setting.

Arora S, Heulitt G, Menon M, Jeong W, Ahlawat RK, Capitanio U, Moon DA, Maes KK, Rawal S, Mottrie A, Bhandari M, Rogers CG, Porter JR.

Urology. 2018 Oct;120:131-137. doi: 10.1016/j.urology.2018.06.026. Epub 2018 Jul 25.

PMID:
30053396
6.

Pathological staging of renal cell carcinoma: a review of 300 consecutive cases with emphasis on retrograde venous invasion.

Taneja K, Arora S, Rogers CG, Gupta NS, Williamson SR.

Histopathology. 2018 Oct;73(4):681-691. doi: 10.1111/his.13672. Epub 2018 Aug 6.

PMID:
29897139
7.

What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy?

Arora S, Keeley J, Pucheril D, Menon M, Rogers CG.

Urol Oncol. 2018 Jul;36(7):339.e17-339.e23. doi: 10.1016/j.urolonc.2018.04.009.

PMID:
29773492
8.

Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men.

Neslund-Dudas CM, McBride RB, Kandegedara A, Rybicki BA, Kryvenko ON, Chitale D, Gupta N, Williamson SR, Rogers CG, Cordon-Cardo C, Rundle AG, Levin AM, Dou QP, Mitra B.

J Trace Elem Med Biol. 2018 Jul;48:233-238. doi: 10.1016/j.jtemb.2018.04.006. Epub 2018 Apr 13.

9.

Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.

Jamal M, Taneja K, Arora S, Barod R, Rogers CG, Sanchez J, Gupta NS, Williamson SR.

Int J Surg Pathol. 2018 Sep;26(6):536-541. doi: 10.1177/1066896918763948. Epub 2018 Mar 21.

PMID:
29560759
10.

Re: Each procedure matters: threshold for surgeon volume to minimize complications and decrease cost associated with adrenalectomy.

Arora S, Rogers CG, Menon M.

Surgery. 2018 Jun;163(6):1325-1329. doi: 10.1016/j.surg.2017.12.024. Epub 2018 Feb 1. No abstract available.

PMID:
29395239
11.

Initial robotic assistance in the surgical management of renal cell carcinoma with level 4 cavoatrial thrombus.

Palma-Zamora I, Dalela D, Barod R, Hsu L, Menon M, Rogers CG.

J Robot Surg. 2018 Dec;12(4):737-740. doi: 10.1007/s11701-017-0766-1. Epub 2017 Dec 4.

PMID:
29204888
12.

Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.

Williamson SR, Hornick JL, Eble JN, Gupta NS, Rogers CG, True L, Grignon DJ, Cheng L.

Hum Pathol. 2018 May;75:10-15. doi: 10.1016/j.humpath.2017.11.013. Epub 2017 Nov 24.

PMID:
29180251
13.

Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated With Radical Prostatectomy.

Nocera L, Sood A, Dalela D, Gild P, Rogers CG, Peabody JO, Montorsi F, Menon M, Briganti A, Abdollah F.

Clin Genitourin Cancer. 2018 Apr;16(2):e451-e467. doi: 10.1016/j.clgc.2017.10.003. Epub 2017 Oct 16.

PMID:
29113771
14.

Unclassified hemangioma-like renal cell carcinoma: a potential diagnostic pitfall.

Taneja K, Arora S, Rogers CG, Gupta NS, Cheng L, Williamson SR.

Hum Pathol. 2018 May;75:132-136. doi: 10.1016/j.humpath.2017.09.015. Epub 2018 Apr 18.

PMID:
29104112
15.

Robot-Assisted Laparoscopic Repair of Extraperitoneal Ureteral Inguinal Hernia with Mesh Placement.

Pucheril D, Chun B, Dalela D, Abdollah F, Laker SA, Rogers CG.

J Endourol Case Rep. 2017 Jul 1;3(1):97-100. doi: 10.1089/cren.2017.0046. eCollection 2017.

16.

Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.

Favazza L, Chitale DA, Barod R, Rogers CG, Kalyana-Sundaram S, Palanisamy N, Gupta NS, Williamson SR.

Mod Pathol. 2017 Nov;30(11):1603-1612. doi: 10.1038/modpathol.2017.72. Epub 2017 Jul 21.

17.

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.

Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS.

Hum Pathol. 2017 May;63:149-156. doi: 10.1016/j.humpath.2017.03.004. Epub 2017 Mar 14.

18.

Robotic Partial Nephrectomy for Posterior Tumors Through a Retroperitoneal Approach Offers Decreased Length of Stay Compared with the Transperitoneal Approach: A Propensity-Matched Analysis.

Maurice MJ, Kaouk JH, Ramirez D, Bhayani SB, Allaf ME, Rogers CG, Stifelman MD.

J Endourol. 2017 Feb;31(2):158-162. doi: 10.1089/end.2016.0603.

PMID:
27927035
19.

Erratum to: Adding a newly trained surgeon into a high-volume robotic prostatectomy group: are outcomes compromised?

Wang L, Diaz M, Stricker H, Peabody JO, Menon M, Rogers CG.

J Robot Surg. 2017 Mar;11(1):75. doi: 10.1007/s11701-016-0642-4. No abstract available.

PMID:
27743311
20.

Adding a newly trained surgeon into a high-volume robotic prostatectomy group: are outcomes compromised?

Wang L, Diaz M, Stricker H, Peabody JO, Menon M, Rogers CG.

J Robot Surg. 2017 Mar;11(1):69-74. doi: 10.1007/s11701-016-0615-7. Epub 2016 Jun 27. Erratum in: J Robot Surg. 2017 Mar;11(1):75.

PMID:
27350553
21.

Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.

Abdollah F, Dalela D, Sood A, Sammon J, Jeong W, Beyer B, Fossati N, Rogers CG, Diaz-Insua M, Peabody J, Haese A, Montorsi F, Graefen M, Briganti A, Menon M.

World J Urol. 2016 Oct;34(10):1357-66. doi: 10.1007/s00345-016-1781-y. Epub 2016 Feb 12.

PMID:
26873596
22.

Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.

Williamson SR, Gupta NS, Eble JN, Rogers CG, Michalowski S, Zhang S, Wang M, Grignon DJ, Cheng L.

Am J Surg Pathol. 2015 Nov;39(11):1502-10. doi: 10.1097/PAS.0000000000000514.

PMID:
26457355
23.

Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1 791 patients.

Potretzke AM, Knight BA, Zargar H, Kaouk JH, Barod R, Rogers CG, Mass A, Stifelman MD, Johnson MH, Allaf ME, Sherburne Figenshau R, Bhayani SB.

BJU Int. 2016 Jan;117(1):131-7. doi: 10.1111/bju.13249. Epub 2015 Sep 6.

24.

Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.

Abdollah F, Sood A, Sammon JD, Hsu L, Beyer B, Moschini M, Gandaglia G, Rogers CG, Haese A, Montorsi F, Graefen M, Briganti A, Menon M.

Eur Urol. 2015 Sep;68(3):497-505. doi: 10.1016/j.eururo.2015.06.020. Epub 2015 Jun 26.

PMID:
26119559
26.

Indications, techniques, outcomes, and limitations for minimally ischemic and off-clamp partial nephrectomy: a systematic review of the literature.

Simone G, Gill IS, Mottrie A, Kutikov A, Patard JJ, Alcaraz A, Rogers CG.

Eur Urol. 2015 Oct;68(4):632-40. doi: 10.1016/j.eururo.2015.04.020. Epub 2015 Apr 25. Review.

PMID:
25922273
27.

A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Klatte T, Ficarra V, Gratzke C, Kaouk J, Kutikov A, Macchi V, Mottrie A, Porpiglia F, Porter J, Rogers CG, Russo P, Thompson RH, Uzzo RG, Wood CG, Gill IS.

Eur Urol. 2015 Dec;68(6):980-92. doi: 10.1016/j.eururo.2015.04.010. Epub 2015 Apr 22. Review.

28.

An evaluation of the timing of surgical complications following nephrectomy: data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).

Sood A, Abdollah F, Sammon JD, Kapoor V, Rogers CG, Jeong W, Klett DE, Hanske J, Meyer CP, Peabody JO, Menon M, Trinh QD.

World J Urol. 2015 Dec;33(12):2031-8. doi: 10.1007/s00345-015-1564-x. Epub 2015 Apr 25.

PMID:
25910477
29.

Chronic hepatitis C infection as a risk factor for renal cell carcinoma.

Gonzalez HC, Lamerato L, Rogers CG, Gordon SC.

Dig Dis Sci. 2015 Jun;60(6):1820-4. doi: 10.1007/s10620-015-3521-3. Epub 2015 Jan 17.

PMID:
25592719
30.

Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Ball MW, Gorin MA, Bhayani SB, Rogers CG, Stifelman MD, Kaouk JH, Zargar H, Marshall S, Larson JA, Rahbar HM, Trock BJ, Pierorazio PM, Allaf ME.

Urol Oncol. 2015 Mar;33(3):112.e9-14. doi: 10.1016/j.urolonc.2014.11.003. Epub 2014 Dec 11.

31.

Nonmodifiable factors and complications contribute to length of stay in robot-assisted partial nephrectomy.

Larson JA, Kaouk JH, Stifelman MD, Rogers CG, Allaf ME, Potretzke A, Marshall S, Zargar H, Ball MW, Bhayani SB.

J Endourol. 2015 Apr;29(4):422-9. doi: 10.1089/end.2014.0424. Epub 2014 Dec 30.

32.

Oncologic outcomes at 10 years following robotic radical prostatectomy.

Diaz M, Peabody JO, Kapoor V, Sammon J, Rogers CG, Stricker H, Lane Z, Gupta N, Bhandari M, Menon M.

Eur Urol. 2015 Jun;67(6):1168-1176. doi: 10.1016/j.eururo.2014.06.025. Epub 2014 Jul 2.

PMID:
24996687
33.

Case report: Renal cell carcinoma with metastasis to the myometrium.

Rahbar HM, Kumar RK, Dalela D, Hanna R, Gupta N, Rogers CG.

J Obstet Gynaecol Res. 2014 Jun;40(6):1828-30. doi: 10.1111/jog.12405.

PMID:
24888959
34.

Robot-assisted partial nephrectomy in patients with baseline chronic kidney disease: a multi-institutional propensity score-matched analysis.

Kumar RK, Sammon JD, Kaczmarek BF, Khalifeh A, Gorin MA, Sivarajan G, Tanagho YS, Bhayani SB, Stifelman MD, Allaf ME, Kaouk JH, Rogers CG.

Eur Urol. 2014 Jun;65(6):1205-10. doi: 10.1016/j.eururo.2013.12.004. Epub 2013 Dec 14.

PMID:
24388436
35.

Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample.

Ghani KR, Sukumar S, Sammon JD, Rogers CG, Trinh QD, Menon M.

J Urol. 2014 Apr;191(4):907-12. doi: 10.1016/j.juro.2013.10.099. Epub 2013 Oct 29.

PMID:
24184365
36.

Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.

Sukumar S, Rogers CG, Trinh QD, Sammon J, Sood A, Stricker H, Peabody JO, Menon M, Diaz-Insua M.

BJU Int. 2014 Dec;114(6):824-31. doi: 10.1111/bju.12404.

37.

Robot-assisted anatrophic nephrolithotomy with renal hypothermia for managing staghorn calculi.

Ghani KR, Rogers CG, Sood A, Kumar R, Ehlert M, Jeong W, Ganpule A, Bhandari M, Desai M, Menon M.

J Endourol. 2013 Nov;27(11):1393-8. doi: 10.1089/end.2013.0266. Epub 2013 Oct 15.

PMID:
23859085
38.

Robot-assisted vs. laparoscopic partial nephrectomy: utilization rates and perioperative outcomes.

Sammon JD, Karakiewicz PI, Sun M, Ravi P, Ghani KR, Jeong W, Bianchi M, Hansen J, Perrotte P, Peabody JO, Rogers CG, Shariat SF, Menon M, Trinh QD.

Int Braz J Urol. 2013 May-Jun;39(3):377-86. doi: 10.1590/S1677-5538.IBJU.2013.03.11.

39.

Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.

Gorin MA, Ball MW, Pierorazio PM, Tanagho YS, Bhayani SB, Kaouk JH, Rogers CG, Stifelman MD, Khalifeh A, Kumar R, Sivarajan G, Allaf ME.

J Urol. 2013 Nov;190(5):1907-11. doi: 10.1016/j.juro.2013.06.014. Epub 2013 Jun 11.

PMID:
23764083
40.

Comparison of robotic and laparoscopic ultrasound probes for robotic partial nephrectomy.

Kaczmarek BF, Sukumar S, Kumar RK, Desa N, Jost K, Diaz M, Menon M, Rogers CG.

J Endourol. 2013 Sep;27(9):1137-40. doi: 10.1089/end.2012.0528. Epub 2013 May 9.

PMID:
23510382
41.

Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers.

Tanagho YS, Kaouk JH, Allaf ME, Rogers CG, Stifelman MD, Kaczmarek BF, Hillyer SP, Mullins JK, Chiu Y, Bhayani SB.

Urology. 2013 Mar;81(3):573-9. doi: 10.1016/j.urology.2012.10.067.

PMID:
23452807
42.

Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.

Trinh QD, Sukumar S, Schmitges J, Bianchi M, Sun M, Shariat SF, Sammon JD, Jeldres C, Zorn KC, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI.

Ann Surg Oncol. 2013 Jun;20(6):2096-102. doi: 10.1245/s10434-012-2806-4. Epub 2012 Dec 23.

PMID:
23263779
43.

Tablet telerounding.

Kaczmarek BF, Trinh QD, Menon M, Rogers CG.

Urology. 2012 Dec;80(6):1383-8. doi: 10.1016/j.urology.2012.06.060.

PMID:
23206790
44.

Intraoperative finding of gross lymph node metastasis during robot-assisted prostatectomy.

Jeong W, Sukumar S, Petros F, Menon M, Peabody JO, Rogers CG.

J Robot Surg. 2012 Dec;6(4):329-32. doi: 10.1007/s11701-011-0316-1. Epub 2011 Sep 27.

PMID:
27628473
45.

Robotic partial nephrectomy with cold ischemia and on-clamp tumor extraction: recapitulating the open approach.

Rogers CG, Ghani KR, Kumar RK, Jeong W, Menon M.

Eur Urol. 2013 Mar;63(3):573-8. doi: 10.1016/j.eururo.2012.11.029. Epub 2012 Nov 19.

PMID:
23183196
46.

Robotic partial nephrectomy for solitary kidney: a multi-institutional analysis.

Hillyer SP, Bhayani SB, Allaf ME, Rogers CG, Stifelman MD, Tanagho Y, Mullins JK, Chiu Y, Kaczmarek BF, Kaouk JH.

Urology. 2013 Jan;81(1):93-7. doi: 10.1016/j.urology.2012.08.055. Epub 2012 Nov 13.

PMID:
23153935
47.

Off-clamp robot-assisted partial nephrectomy preserves renal function: a multi-institutional propensity score analysis.

Kaczmarek BF, Tanagho YS, Hillyer SP, Mullins JK, Diaz M, Trinh QD, Bhayani SB, Allaf ME, Stifelman MD, Kaouk JH, Rogers CG.

Eur Urol. 2013 Dec;64(6):988-93. doi: 10.1016/j.eururo.2012.10.009. Epub 2012 Oct 16.

PMID:
23122834
48.

Tumor complexity predicts malignant disease for small renal masses.

Mullins JK, Kaouk JH, Bhayani S, Rogers CG, Stifelman MD, Pierorazio PM, Tanagho YS, Hillyer SP, Kaczmarek BF, Chiu Y, Allaf ME.

J Urol. 2012 Dec;188(6):2072-6. doi: 10.1016/j.juro.2012.08.027. Epub 2012 Oct 18.

PMID:
23083863
49.

Robotic ultrasound probe for tumor identification in robotic partial nephrectomy: Initial series and outcomes.

Kaczmarek BF, Sukumar S, Petros F, Trinh QD, Mander N, Chen R, Menon M, Rogers CG.

Int J Urol. 2013 Feb;20(2):172-6. doi: 10.1111/j.1442-2042.2012.03127.x. Epub 2012 Aug 26.

50.

The effect of gender on nephrectomy perioperative outcomes: a national survey.

Sammon J, Trinh QD, Sun M, Bianchi M, Schmitges J, Shariat SF, Ghani KR, Sukumar S, Jeldres C, Briganti A, Perrotte P, Rogers CG, Peabody JO, Montorsi F, Menon M, Karakiewicz PI.

Can J Urol. 2012 Aug;19(4):6337-44.

PMID:
22892256

Supplemental Content

Loading ...
Support Center